| Completed | Lenalidomide and R-CHOP in B-cell Lymphoma Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma, Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2009-01-06 |
| Completed | Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma Lymphoma, Follicular | — | 2007-09-18 |
| Completed | Targeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cel Lymphoma, Large Cell, Diffuse | Phase 2 | 2007-08-01 |
| Completed | Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Pati Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma | Phase 2 | 2007-07-01 |
| Terminated | Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2007-06-01 |
| Completed | Mini-CHOP and Rituximab in Patients Aged Over 80 Years Diffuse Large B-Cell Lymphoma | Phase 2 | 2006-04-01 |
| Completed | Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma | Phase 2 | 2006-01-08 |
| Completed | A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma Untreated T-cell Angioimmunoblastic Lymphoma | Phase 2 | 2005-12-01 |
| Terminated | A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma Follicular Lymphoma | Phase 2 | 2005-09-01 |
| Completed | Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma B-Cell Lymphoma | Phase 2 | 2005-03-01 |
| Completed | Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma B Cell Lymphoma | Phase 2 | 2005-01-01 |
| Completed | Primary Rituximab and Maintenance Follicular Lymphoma | Phase 3 | 2004-12-01 |
| Completed | Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma Untreated CD20-positive Large B-cell Lymphoma | Phase 2 | 2004-05-01 |
| Terminated | ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma Diffuse Large Cell Lymphoma | Phase 3 | 2003-12-01 |
| Completed | ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjuste Diffuse Large-Cell Lymphoma | Phase 3 | 2003-12-01 |
| Completed | ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma Diffuse Large Cell Lymphoma | Phase 2 | 2003-12-01 |
| Completed | R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lympho Diffuse Large Cell Lymphoma | Phase 3 | 2003-12-01 |
| Completed | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma Lymphoma, Large-Cell, Diffuse | Phase 3 | 2003-06-01 |
| Completed | Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma Diffuse Large Cell Lymphoma | Phase 2 | 2003-04-01 |
| Terminated | R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma Lymphoma, Large-Cell, Diffuse | Phase 3 | 2001-10-16 |
| Completed | Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymph Follicular Lymphoma | Phase 2 | 2001-04-01 |
| Completed | Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden Lymphoma | Phase 3 | 2000-05-01 |
| Terminated | Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma CD20-Positive Large B-Cell Lymphoma | Phase 3 | 1999-10-01 |
| Completed | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma Lymphoma, Large-Cell, Diffuse | Phase 2 / Phase 3 | 1999-10-01 |
| Unknown | Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With R Lymphoma | Phase 3 | 1995-10-01 |
| Completed | Randomized Study for Patients With Follicular Lymphoma Needing Treatment Follicular Lymphoma | Phase 3 | 1994-01-01 |